Lunit

Lunit is a medical AI company based in Seoul, South Korea, that builds software for cancer detection and precision oncology. Its two main product lines are Lunit INSIGHT and Lunit SCOPE. INSIGHT analyzes radiology images, including chest X-rays, 2D mammography, and 3D digital breast tomosynthesis, to help radiologists flag signs of lung and breast cancer earlier. SCOPE works with pathology slides instead, using AI to analyze tumor tissue and the tumor microenvironment, quantify biomarkers such as HER2 and PD-L1 through its IHC Suite, and support genotype prediction. The company's customers are radiologists and imaging centers, oncologists and treatment centers, and biopharma companies that need companion diagnostics or support for clinical trials. Lunit INSIGHT has received FDA clearance and CE marking, and the company reports its products are in use at more than 10,000 sites across 70-plus countries. Lunit was founded in 2013. The tools are built to integrate into existing clinical workflows and partner with radiology technology vendors rather than function as a standalone consumer product, so hospitals and labs typically deploy them through their existing imaging or pathology systems. One limitation of the available information is that specific supported platforms, named third-party integration partners, and API details are not spelled out publicly.